Lataa...
How Effective Is the Fixed-Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) in Different Patient Populations, and When Should It Be Used in Clinical Practice?
The efficacy and safety of the fixed-ratio combination of insulin degludec (degludec) and liraglutide (IDegLira) were confirmed in the DUAL clinical trial program, in which IDegLira demonstrated superior or noninferior glycemic control over comparators in addition to its low risks of hypoglycemia an...
Tallennettuna:
| Julkaisussa: | Clin Diabetes |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Diabetes Association
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7566936/ https://ncbi.nlm.nih.gov/pubmed/33132503 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/cd20-0014 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|